Lumida
/STRO
⌘K
Sutro Biopharma Inc

Sutro Biopharma Inc

STRO
$20.50USD+0.15%+0.03 today

MARKET CAP

340.6M

P/E (TTM)

FWD P/E

DAY RANGE

$21 – $21

52W RANGE

$7
$44
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$61.9M$67.8M$153.7M$62.0M$102.5M
YoY %+44.8%+9.5%+126.8%-59.6%+65.2%
P / Sales110.9x6.0x1.8x2.3x1.0x
EV / Sales111.8x8.1x3.4x4.7x3.4x
Gross Profit, Adj.$61.9M$67.8M$153.7M$62.0M$102.5M
YoY %+44.8%+9.5%+126.8%-59.6%+65.2%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit111.8x8.1x3.4x4.7x3.4x
EBITDA, Adj.$-93.7M$-123.3M$-82.5M$-231.2M$-97.6M
YoY %-40.3%-31.6%+33.1%-180.4%+57.8%
Margin %-151.4%-181.9%-53.6%-372.7%-95.3%
EV / EBITDA-73.9x-4.5x-6.4x-1.3x-3.5x
EBIT$-98.5M$-128.9M$-89.3M$-238.5M$-158.4M
YoY %-38.7%-30.9%+30.8%-167.1%+33.6%
Margin %-159.2%-190.3%-58.1%-384.3%-154.5%
EV / EBIT-70.2x-4.3x-5.9x-1.2x-2.2x
Net Income$-105.5M$-119.2M$-106.8M$-227.5M$-191.1M
YoY %-228.5%-12.9%+10.4%-113.0%+16.0%
Net Margin-170.6%-175.9%-69.5%-366.6%-186.5%
EPS (GAAP)-$2.29-$23.50-$17.80-$29.40-$22.49
YoY %-131.3%-926.2%+24.3%-65.2%+23.5%